Posts by: Marta Figueiredo

News

Adding BioLineRx‘s BL-8040 to standard treatment greatly improves the mobilization of blood stem cells to be collected for stem cell transplants in patients with multiple myeloma, according to interim ... Read more

July 2, 2018July 2, 2018

Advanced Blood Sample Analysis Could Be Better Than Bone Marrow Biopsies, Study Shows

News

Genetic analysis of multiple myeloma DNA from two different sources present in blood samples provides researchers equally relevant cancer information as more invasive bone marrow biopsies, a study shows. ... Read more

May 21, 2018

MS Therapy May Ease Painful Side Effect of Velcade Treatment in Myeloma Patients, Study Says

News

A multiple sclerosis (MS) treatment reduced a common painful side effect of Velcade (bortezomib) in a mouse model, suggesting that it might help myeloma patients complete their treatment and ... Read more

May 11, 2018

FDA Approves Darzalex Combo Therapy for Certain Newly Diagnosed Patients

News

The U.S. Food and Drug Administration (FDA) has approved Darzalex (daratumumab) in combination with standard therapy for the treatment of patients with newly-diagnosed multiple myeloma who are not eligible for stem ... Read more

May 9, 2018May 10, 2018

Selinexor May Bring Hope to Heavily Treated Myeloma Patients, Trial Results Show

News

A quarter of heavily treated patients with penta-refractory multiple myeloma responded to Karyopharm‘s investigative oral therapy selinexor (KPT-330), according to top-line data from a Phase 2 study. The results bring ... Read more

May 2, 2018May 2, 2018

Chip-based Blood Test Might Replace Bone Marrow Biopsies for Myeloma, Scientists Say

News

Researchers say they have developed a low-cost, reliable, chip-based blood test to detect multiple myeloma, which could replace the painful bone marrow biopsy. Their study, “Isolation of Circulating Plasma ... Read more

December 20, 2017December 20, 2017

Biomarker Found That Detects Myeloma Patients Who Will Benefit from Stem Cell Transplant

News

A collaboration between GNS Healthcare and the Multiple Myeloma Research Foundation (MMRF) resulted in the discovery of a biomarker called CHEK1 that detects which myeloma patients might benefit from a ... Read more

December 15, 2017

Adaptimmune Immunotherapy Increases Time It Takes for Myeloma to Progress, Trial Shows

News

An Adaptimmune therapy that strengthens immune T-cells’ response to cancer has helped patients with advanced myeloma live as long as five years without their disease progressing, long-term results of a Phase ... Read more